Plasmodium falciparum infection
Information
- Disease name
- Plasmodium falciparum infection
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05304611 | Active, not recruiting | Phase 2 | Anti-malaria MAb in Malian Children | March 18, 2022 | April 2024 |
| NCT00379821 | Completed | Phase 3 | Chloroquine Alone or in Combination for Malaria in Children in Malawi | February 2007 | September 2012 |
| NCT00744133 | Completed | Phase 1 | Malaria Challenge With NF54 Strain | March 2009 | November 2011 |
| NCT02020330 | Completed | Phase 3 | Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day | November 25, 2013 | March 25, 2015 |
| NCT02143934 | Completed | Phase 4 | Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity | August 2009 | May 2014 |
| NCT02353494 | Completed | Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria | March 2015 | May 2016 | |
| NCT05816330 | Completed | Phase 2 | L9LS MAb in Malian Adults | May 25, 2023 | February 11, 2024 |
| NCT03168854 | Completed | Phase 1 | Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites | July 26, 2017 | August 16, 2019 |
| NCT03589794 | Completed | Phase 1 | rCSP/AP10-602 [GLA-LSQ] Vaccine Trial | December 21, 2018 | July 5, 2022 |
| NCT03660839 | Completed | Phase 2 | Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria | September 11, 2018 | November 6, 2019 |
| NCT04329104 | Completed | Phase 2 | Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali | February 15, 2021 | July 5, 2023 |
| NCT00371189 | Completed | Phase 1 | Adenovirus Vaccine for Malaria | January 2007 | June 2014 |
| NCT02663700 | Completed | Phase 1 | Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso | April 7, 2016 | December 17, 2018 |
| NCT02773979 | Completed | Phase 1 | PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States | September 12, 2016 | January 22, 2018 |
| NCT02780154 | Completed | Phase 1 | PfSPZ Challenge in Non-immune Adults in Baltimore, USA | August 25, 2016 | December 15, 2016 |
| NCT02996695 | Completed | Phase 1 | Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults | April 6, 2017 | June 22, 2018 |
| NCT03014258 | Completed | Phase 1 | A Systems Biology Approach to Malaria Immunity | June 7, 2017 | July 19, 2019 |
| NCT05750459 | Recruiting | Phase 4 | Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria | November 29, 2023 | December 30, 2024 |
| NCT05400655 | Recruiting | Phase 2 | Anti-malaria MAb in Kenyan Children | September 14, 2022 | June 30, 2024 |
| NCT02497612 | Terminated | Phase 2 | To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria | July 25, 2015 | September 23, 2019 |
| NCT00988507 | Terminated | Phase 2 | Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria | October 2009 | November 2010 |
| NCT05025761 | Unknown status | N/A | Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar | January 1, 2022 | June 2022 |